What is Valerie Baca's NPI number?

Valerie Baca's National Provider Identifier (NPI) is 1629715784, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Valerie Baca's specialty?

Valerie Baca is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).

Where is Valerie Baca located?

Valerie Baca's practice location on file with NPPES is 6565 West Loop S Ste 650, Bellaire, TX 77401-3505.

What is Valerie Baca's phone number?

The practice phone number listed in the NPPES registry for Valerie Baca is (713) 797-1010.

Does Valerie Baca accept Medicare?

Valerie Baca is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Valerie Baca's NPI active?

Yes — Valerie Baca's NPI (1629715784) is active in the NPPES registry as of the last update on 2022-05-18.

IndividualActiveAccepts Medicare

Valerie Baca

NPI 1629715784 · Optometrist · Bellaire, TX

Valerie Baca is a Optometrist provider in Bellaire, TX (NPI 1629715784).

Provider details

NPI number: 1629715784
Entity type: Individual
Primary specialty: OptometristEye and Vision Services Providers
Sex: Female
Sole proprietor: No
License: 10255T (TX)

Practice location

6565 West Loop S Ste 650

Bellaire, TX 77401-3505

Phone: (713) 797-1010

Approximate (ZIP-level) locationGet directions

More TX providers

Mailing address

6565 West Loop S Ste 650

Bellaire, TX 77401-3505

Specialties & taxonomies

OptometristPrimary152W00000XLicense 10255T (TX)
Eye and Vision Services Providers

Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(65/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
4 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
967 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Problem Focused Exam of Visual System92012	351	$88
Established Patient Complete Exam of Visual System92014	189	$125
Imaging of Retina92134	174	$40
Exam of Visual Field With Extended Testing92083	59	$63
Imaging of Optic Nerve92133	52	$36
New Patient Complete Exam of Visual System92004	46	$146
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Prednisolone Acetate	121	107
Latanoprost	81	29
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	55	45
Bimatoprostbrand: Lumigan	42	19
Cyclosporinebrand: Restasis	31	16
Doxycycline Hyclate	30	23
Lifitegrastbrand: Xiidra	29	15

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,069 across 54 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2022-05-18
Last updated: 2022-05-18
Certified: 2022-05-18

Frequently asked questions

What is Valerie Baca's NPI number?: Valerie Baca's National Provider Identifier (NPI) is 1629715784, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Valerie Baca's specialty?: Valerie Baca is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
Where is Valerie Baca located?: Valerie Baca's practice location on file with NPPES is 6565 West Loop S Ste 650, Bellaire, TX 77401-3505.
What is Valerie Baca's phone number?: The practice phone number listed in the NPPES registry for Valerie Baca is (713) 797-1010.
Does Valerie Baca accept Medicare?: Valerie Baca is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Valerie Baca's NPI active?: Yes — Valerie Baca's NPI (1629715784) is active in the NPPES registry as of the last update on 2022-05-18.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Problem Focused Exam of Visual System92012	351	$88
Established Patient Complete Exam of Visual System92014	189	$125
Imaging of Retina92134	174	$40
Exam of Visual Field With Extended Testing92083	59	$63
Imaging of Optic Nerve92133	52	$36
New Patient Complete Exam of Visual System92004	46	$146
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Prednisolone Acetate	121	107
Latanoprost	81	29
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	55	45
Bimatoprostbrand: Lumigan	42	19
Cyclosporinebrand: Restasis	31	16
Doxycycline Hyclate	30	23
Lifitegrastbrand: Xiidra	29	15

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,069 across 54 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments